Welcome to our dedicated page for Healthcare Tr Amer SEC filings (Ticker: HR), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Healthcare Realty Trust Incorporated (NYSE: HR) files a range of reports and disclosure documents with the U.S. Securities and Exchange Commission (SEC) that provide detailed information about its operations as a healthcare‑focused real estate investment trust. This page aggregates those SEC filings for HR and pairs them with AI‑generated summaries to help readers understand the key points in each document.
In its periodic filings, such as the Annual Report on Form 10‑K and Quarterly Reports on Form 10‑Q, Healthcare Realty presents consolidated financial statements, portfolio data and management’s discussion and analysis. These filings expand on metrics referenced in the company’s earnings releases, including rental income from medical outpatient buildings, property operating expenses, funds from operations (FFO), normalized FFO, funds available for distribution (FAD), leverage measures and information about its medical outpatient building portfolio and development pipeline.
Current reports on Form 8‑K provide timely updates on specific events. For Healthcare Realty, recent 8‑Ks have addressed topics such as quarterly earnings and dividend announcements, changes to the Board of Directors, the appointment and departure of its Executive Vice President and Chief Financial Officer, amendments to its revolving credit and term loan facilities and the establishment of an at‑the‑market equity offering program. These filings often include or reference press releases, supplemental information packages and credit agreements.
Investors can also use this page to access other SEC documents related to Healthcare Realty, such as registration statements and exhibits describing its unsecured credit facilities and equity distribution agreements. For those monitoring governance and executive matters, 8‑K filings under Item 5.02 outline executive appointments, employment agreement terms, severance and change‑in‑control provisions.
Stock Titan enhances these filings with AI‑powered tools. Real‑time updates from the SEC’s EDGAR system ensure that new 10‑K, 10‑Q and 8‑K filings appear promptly. AI‑generated summaries highlight key financial metrics, capital structure changes, portfolio updates and governance actions, helping readers navigate lengthy documents more efficiently. Users can also review insider‑related information when reported on Forms 3, 4 or 5, and examine proxy‑related disclosures when filed, to better understand executive compensation and board structure.
Whether you are analyzing Healthcare Realty’s leverage and liquidity, reviewing its credit facilities and equity offering programs, or tracking leadership and board changes, this SEC filings page provides a centralized view of the company’s regulatory disclosures with added AI context.
Healthcare Realty Trust Inc reported that an executive officer who serves as EVP and CIO had 908 common shares withheld on 12/13/2025 to satisfy required tax withholding obligations related to the vesting of previously granted restricted shares.
The transaction was reported at a price of $17.18 per share and left the officer with 166,826 common shares owned directly. The filing describes this as shares withheld by the issuer in connection with the restricted stock vesting rather than a typical discretionary share sale.
Healthcare Realty Trust Inc. disclosed an insider share disposition by its EVP and General Counsel, Andrew E. Loope. On 12/13/2025, 2,686 shares of common stock were surrendered at $17.18 per share to the company to satisfy required tax withholding tied to the vesting of previously granted restricted shares. After this tax-withholding transaction, he directly beneficially owned 160,747 common shares.
Healthcare Realty Trust Inc. disclosed an insider equity transaction involving its SVP & Chief Accounting Officer, Andrew E. Loope. On 12/13/2025, 2,481 shares of common stock were withheld by the company to cover required tax withholding related to the vesting of previously granted restricted shares, rather than being sold on the open market. The transaction was recorded at a price of $ 17.18 per share. Following this withholding event, Loope directly beneficially owned 107,546 shares of Healthcare Realty Trust common stock.
Healthcare Realty Trust Inc. reported a routine insider transaction by its SVP & Chief Accounting Officer. On 12/04/2025, the officer had 992 shares of common stock withheld by the company at a price of $17.46 per share to cover required tax withholding related to the vesting of previously granted restricted shares.
Following this tax-withholding transaction, the officer directly beneficially owns 110,027 shares of Healthcare Realty Trust Inc. common stock. The filing is administrative in nature and reflects no open-market purchase or sale.
Healthcare Realty Trust Inc.: Cohen & Steers filed Amendment No. 2 to Schedule 13G reporting beneficial ownership of 56,429,507 shares of common stock, representing 16.05% of the class as of 09/30/2025. Cohen & Steers, Inc. reports sole voting power over 42,824,616 shares and sole dispositive power over 56,429,507 shares.
Subsidiaries reported stakes include Cohen & Steers Capital Management, Inc. with 55,840,490 shares (15.88%), Cohen & Steers UK Limited with 544,974 shares (0.15%), and Cohen & Steers Ireland Limited with 44,043 shares (0.01%). The filing certifies the securities were acquired and are held in the ordinary course and not for the purpose of changing or influencing control.
Healthcare Realty Trust (HR) reported Q3 2025 results. Total revenues were $297.8 million, down from $315.4 million a year ago, as rental income eased to $287.4 million from $306.5 million. The company recorded a net loss attributable to common stockholders of $57.7 million versus a $93.0 million loss last year, as property impairments and interest expense continued to weigh on results.
Portfolio recycling accelerated. Year-to-date real estate dispositions reached $477.6 million in sale price, generating $447.3 million of net proceeds and $75.5 million of gains. Assets held for sale grew to 43 properties and two land parcels, with $604.7 million classified as held for sale, reflecting an ongoing pruning strategy.
Non-cash charges remained significant. The company recognized $104.4 million of real estate impairments in Q3 and $255.4 million year-to-date. Q3 interest expense was $52.6 million.
Balance sheet updates. HR repaid $250 million senior notes in May and entered a new $1.5 billion unsecured revolving credit facility on July 25, 2025, extended to 2029; $149 million was drawn at quarter-end. Operating cash flow for the nine months was $324.8 million. Shares outstanding were 351.6 million as of October 24, 2025.
Healthcare Realty Trust (HR) filed an 8‑K stating it issued a press release announcing its earnings and dividend for the third quarter ended September 30, 2025. The company also furnished its Q3 2025 Supplemental Information. The press release is included as Exhibit 99.1 and the supplemental package as Exhibit 99.2, and both are referenced as available via the company’s website.
Starboard-affiliated funds report holding 14,492,496 shares of Healthcare Realty Trust Inc (HR), equal to 4.1% of the Class A common stock based on 351,606,597 shares outstanding as of July 25, 2025. The filing amends prior disclosures to specify that portions of these holdings were purchased in the open market using working capital and gives aggregate purchase-price amounts by fund: Starboard V&O Fund ~8,007,983 shares for $131,335,340; Starboard S LLC ~1,158,671 shares for $19,016,386; Starboard L Master ~485,662 shares for $7,963,596; Starboard X Master ~2,976,770 shares for $48,949,159; and 1,863,410 shares held in the Starboard Value LP account for ~$32,170,068, all excluding commissions.
The amendment also discloses that Starboard V&O Fund exercised forward purchase contracts with Bank of America to acquire 4,826,156 shares (the BA Forward Contracts) and is no longer a party to those contracts. The filing states that, as of September 23, 2025, the reporting persons ceased to beneficially own more than 5% of the issuer.
Julie F. Wilson, EVP and Chief Administrative Officer and a director of Healthcare Realty Trust Inc. (HR), reported a sale of 15,000 shares of HR common stock on 09/05/2025 at a reported price of $18 per share. After the transaction she beneficially owned 113,419 shares. The Form 4 was submitted under power of attorney by Andrew E. Loope.
Form 144 notice for Healthcare Realty Trust Incorporated (HR) reports a proposed sale of 15,000 shares of common stock through Charles Schwab with an aggregate market value of $262,050. The filing lists 351,606,597 shares outstanding and an approximate sale date of 09/04/2025 on the NYSE. The shares to be sold were acquired as equity compensation: 11,303 shares granted on 12/01/2019 and 3,697 shares granted on 12/01/2022, with payment/vesting events recorded on 12/11/2024. The filer reports no sales of the issuer's securities in the past three months and includes the standard signature representation regarding absence of undisclosed material information.